tiprankstipranks
Global Blood Therapeutics (GBT)
NASDAQ:GBT

Global Blood Therapeutics (GBT) Hedge Fund Trading Activity

0 Followers
Trend: Hedge Funds Decreased Holdings by 429.1K Shares Last Quarter

Hedge Fund Holdings in GBT

Based on the 13F filings of 479 Hedge Funds submitted to the SEC.
See how hedge fund holdings have changed over the past year. The columns represent the number of shares owned by hedge funds.

Hedge Fund Confidence Signal

Negative
Stock Sentiment
Sold
Bought
Based on activity of 7 Hedge Funds in the recent quarter
A unique signal which shows hedge fund sentiment according to recent transactions.

Hedge Fund Activity​

Hedge Fund Manager
Star Ranking
Firm
Activity
Holding Change
Value Reported
% of Portfolio
Follow
Moore Capital Management LP
Sold Out
-100.00%
0.00%
Farallon Capital Management, L.L.C.
Sold Out
-100.00%
0.00%
Elkhorn Partners Limited Partnership
Added
9.73%
$594270
0.38%
Graham Capital Management, L.P.
New
100.00%
$1874282
0.08%
Driehaus Capital Management LLC
New
100.00%
$25747258
0.42%
Fairmount Funds Management Llc
Reduced
-19.36%
$30461002
6.97%
Perceptive Advisors LLC
Reduced
-22.54%
$96330975
3.02%

FAQ

Which hedge funds hold Global Blood Therapeutics?
The hedge funds that hold the most shares in Global Blood Therapeutics are Joseph Edelman, Peter Harwin and Richard Driehaus.
    Are hedge funds buying or selling GBT?
    In the last quarter hedge funds have Decreased their holdings in Global Blood Therapeutics by 429.1K shares.
      Where can I see a list of the best rated hedge funds?
      You can see a list of the best hedge funds here.
        Who is the best-performing hedge fund manager?
        The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
          Does Warren Buffet hold shares in Global Blood Therapeutics stock?
          Warren Buffet currently does not own shares in Global Blood Therapeutics.
          What is a 13F filing, and how does it help investors?
          A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis